Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Antigen specificity of clonally enriched CD8(+) T cells in multiple sclerosis.
PMID 41644766 · PMC12956596 · Nature immunology · 2026 · 8 claims · 7 setups
A subset of 23 highly expanded, CSF-enriched CD8+ T cell clonotypes exists predominantly in the CSF of the MS/CIS cohort.
-
Full-text index only
Novel approaches for identifying target antigens of autoreactive human B and T cells.
PMID 19763575 · PMC2845891 · Seminars in immunopathology · 2009 · 8 claims · 8 setups
CD8+ T cells infiltrating MS brain and IM muscle tissue show clonal expansions consistent with antigen-driven selection
-
Full-text index only
Metabolic quiescence of naive-like memory T cells precedes and maintains antigen-specific T cell memory.
PMID 41735532 · PMC12956582 · Nature immunology · 2026 · 8 claims · 8 setups
CD8+ T cells upregulate glycolysis to fuel anabolic needs for proliferation but predominantly use oxidative phosphorylation (OXPHOS) for energy production during the acute phase (days 7-28) after YFV vaccination
-
Full-text index only
Loss of SOCS1 in Donor T Cells Exacerbates Intestinal GVHD by Driving a Chemokine-Dependent Pro-Inflammatory Immune Microenvironment.
PMID 41580972 · PMC13042394 · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026 · 8 claims · 8 setups
T cell-specific Socs1 loss intrinsically drives pro-inflammatory T cell differentiation independent of antigen stimulation, with the strongest effects in CD8+ T cells
-
Full-text index only
Tumour-intrinsic features shape T cell differentiation through precursor to symptomatic multiple myeloma.
PMID 41644568 · PMC12982522 · Nature communications · 2026 · 8 claims · 6 setups
MM is not characterized by T cell exhaustion but by antigen-driven terminal memory differentiation, unlike solid cancers
-
Full-text index only
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.
PMID 41593194 · PMC13004670 · Nature medicine · 2026 · 8 claims · 5 setups
PD-1 blockade induces tumor-specific IgG1+ plasma cell responses that complement cellular immunity and contribute to clinical benefit